Pfizer Inc (PFE)

Add to Watchlists
Create an Alert
42.40 +0.43  +1.02% NYSE Feb 15, 20:00 Delayed 2m USD

Pfizer Inc Research and Development Expense (TTM):

8.005B for Dec. 31, 2018
View 4,000+ financial data types
View Full Chart

Pfizer Inc Research and Development Expense (TTM) Chart

Export Data
Save Image
Print Image

Pfizer Inc Historical Research and Development Expense (TTM) Data

View and export this data going back to 1984. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2018 8.005B
Sept. 30, 2018 7.838B
June 30, 2018 7.695B
March 31, 2018 7.685B
Dec. 31, 2017 7.658B
Sept. 30, 2017 7.88B
June 30, 2017 7.896B
March 31, 2017 7.857B
Dec. 31, 2016 7.872B
Sept. 30, 2016 7.708B
June 30, 2016 7.549B
March 31, 2016 7.535B
Dec. 31, 2015 7.689B
Sept. 30, 2015 8.55B
June 30, 2015 8.63B
March 31, 2015 8.655B
Dec. 31, 2014 8.393B
Sept. 30, 2014 6.995B
June 30, 2014 6.82B
March 31, 2014 6.591B
Dec. 31, 2013 6.678B
Sept. 30, 2013 6.888B
June 30, 2013 7.148B
March 31, 2013 7.218B
Dec. 31, 2012 7.57B
Sept. 30, 2012 7.743B
June 30, 2012 8.032B
March 31, 2012 8.663B
Dec. 31, 2011 8.692B
Sept. 30, 2011 9.391B
June 30, 2011 9.403B
March 31, 2011 9.353B
Dec. 31, 2010 9.483B
Sept. 30, 2010 9.403B
June 30, 2010 8.847B
March 31, 2010 8.381B
Dec. 31, 2009 7.865B
Sept. 30, 2009 7.988B
June 30, 2009 8.241B
March 31, 2009 8.648B
Dec. 31, 2008 8.734B
Sept. 30, 2008 8.058B
June 30, 2008 8.172B
March 31, 2008 8.215B
Dec. 31, 2007 8.089B
Sept. 30, 2007 8.241B
June 30, 2007 8.144B
March 31, 2007 7.721B
Dec. 31, 2006 7.599B
Sept. 30, 2006 7.156B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More


PFE Research and Development Expense (TTM) Benchmarks

Abbott Laboratories 2.30B
Amgen Inc 3.737B
Biogen Inc 2.710B

PFE Research and Development Expense (TTM) Range, Past 5 Years

Minimum 6.591B Mar 2014
Maximum 8.655B Mar 2015
Average 7.775B

PFE Research and Development Expense (TTM) Excel Add-In Codes

  • Metric Code: r_and_d_expense_ttm
  • Latest data point: =YCP("PFE", "r_and_d_expense_ttm")
  • Last 5 data points: =YCS("PFE", "r_and_d_expense_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.




Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.